rs587784396
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006516.4(SLC2A1):c.748C>T(p.Gln250*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q250Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006516.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Encephalopathy due to GLUT1 deficiency Pathogenic:2
- -
- -
not provided Pathogenic:1
p.Gln250Stop (CAG>TAG): c.748 C>T in exon 6 of the SLC2A1 gene (NM_006516.2)The Gln250Stop nonsense mutation in the SLC2A1 gene is predicted to cause loss of normal protein function through protein truncation. Additionally, several other missense and nonsense mutations associated with GLUT1 deficiency syndrome have been reported in this region of the protein. The Gln250Stop mutation has not been reported previously to our knowledge. The variant is found in EPILEPSY panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at